$IVST Provides December Shareholder Update Featuri
Post# of 372
(Total Views: 279)
Posted On: 12/17/2018 8:33:09 AM
$
IVST
Provides December Shareholder Update Featuring Acquisition Update, Revenue Growth, Biotech Progress
GlobeNewswire•December 17, 2018
CLEVELAND, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC Markets: IVST ) (the “Company” or “Innovest”), a conglomerate with operations in commercial and industrial products and services, biotechnology, and construction & building materials, has successfully completed the due diligence phase of the ‘Midwest Curtainwalls’ acquisition (click for details). The next step is agreeing to final documents, and scheduling a closing.
Other notable November items include:
November revenue of $1.95 million marks significant growth from new business, and is four-times our previous monthly sales record
Current assets $3.5 million
Cash balance $730,000
Energy Group recorded its highest monthly revenue to date
Safety Group signed top ranked University Hospitals to four-year contract
Authority National Supply (ANS) acquisition closed, new ANS board established
Biotech Division introduced new board of renown experts (click for details)
IVST average 2018 Price Per Share traded in November: $0.45, October: $0.273, September: $0.251, April: $0.064, January: $0.025
Unchanged free-trading float of 11,796,710 common shares confirmed by transfer agent December 13, 2018; 138 million total shares outstanding
No convertible debts, no warrants or options outstanding
At November average price of $0.45 stock performance is up 1,700% on the year
About Innovest Global, Inc.
Innovest Global, Inc. (OTC Markets: IVST) is a conglomerate with operations in three divisions, which include commercial and industrial products and services, energy, biotechnology, health sciences, construction, and building materials. The primary growth strategy of Innovest Global Inc is to acquire existing companies in a select few industries and attract new customers in cost effective ways. Currently, Innovest Global Inc has a Commercial & Industrial Division, a Biotechnology & Health Services Division, and a Construction & Building Materials Division.
For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter @innovestglobal.
GlobeNewswire•December 17, 2018
CLEVELAND, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC Markets: IVST ) (the “Company” or “Innovest”), a conglomerate with operations in commercial and industrial products and services, biotechnology, and construction & building materials, has successfully completed the due diligence phase of the ‘Midwest Curtainwalls’ acquisition (click for details). The next step is agreeing to final documents, and scheduling a closing.
Other notable November items include:
November revenue of $1.95 million marks significant growth from new business, and is four-times our previous monthly sales record
Current assets $3.5 million
Cash balance $730,000
Energy Group recorded its highest monthly revenue to date
Safety Group signed top ranked University Hospitals to four-year contract
Authority National Supply (ANS) acquisition closed, new ANS board established
Biotech Division introduced new board of renown experts (click for details)
IVST average 2018 Price Per Share traded in November: $0.45, October: $0.273, September: $0.251, April: $0.064, January: $0.025
Unchanged free-trading float of 11,796,710 common shares confirmed by transfer agent December 13, 2018; 138 million total shares outstanding
No convertible debts, no warrants or options outstanding
At November average price of $0.45 stock performance is up 1,700% on the year
About Innovest Global, Inc.
Innovest Global, Inc. (OTC Markets: IVST) is a conglomerate with operations in three divisions, which include commercial and industrial products and services, energy, biotechnology, health sciences, construction, and building materials. The primary growth strategy of Innovest Global Inc is to acquire existing companies in a select few industries and attract new customers in cost effective ways. Currently, Innovest Global Inc has a Commercial & Industrial Division, a Biotechnology & Health Services Division, and a Construction & Building Materials Division.
For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter @innovestglobal.
(1)
(0)Innovest Global, Inc. (IVST) Stock Research Links
What I post is my opinion. Do your own DD. Make your own investment decision. Links, images, & retweets are not endorsements.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.